Suspension of proactive recommendations for HPV vaccination has led to a significant increase in HPV infection rates in young Japanese women: real-world data

QR Code

Suspension of proactive recommendations for HPV vaccination has led to a significant increase in HPV infection rates in young Japanese women: real-world data

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Masayuki Sekine, Manako Yamaguchi, Risa Kudo, Sharon J.B. Hanley, Yutaka Ueda, Sosuke Adachi, Megumi Kurosawa, Etsuko Miyagi, Megumi Hara, Takayuki Enomoto
Format:	article
Langue:	EN
Publié:	Elsevier 2021
Sujets:	HPV vaccine HPV infection cervical cancer Japanese women Public aspects of medicine RA1-1270
Accès en ligne:	https://doaj.org/article/cbe84e6ac2474e2589f899ed0923bd9f
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

HPV and Recurrent Respiratory Papillomatosis: A Brief Review
par: Amr Mohamed Ouda, et autres
Publié: (2021)

Risk factors for HPV infection and high-grade cervical disease in sexually active Japanese women
par: Manako Yamaguchi, et autres
Publié: (2021)

A New HPV score System Predicts the Survival of Patients With Cervical Cancers
par: Qunchao Hu, et autres
Publié: (2021)

A case of HPV-53-related cervical cancer in an elderly patient
par: Lieveld M, et autres
Publié: (2014)

Cervical Cancer Protection in Japan: Where Are We?
par: Asami Yagi, et autres
Publié: (2021)

Hpv-Associated Penile Pigmented Lesion
par: Ananiev J., et autres
Publié: (2014)

Exploring the roles of HPV16 variants in head and neck squamous cell carcinoma: current challenges and opportunities
par: Daniela Cochicho, et autres
Publié: (2021)

A Data Analytics Approach for Revealing Influencing Factors of HPV-Related Cancers From Population-Level Statistics Data
par: Xiaoqin Du, et autres
Publié: (2021)

E7-Targeted Nanotherapeutics for Key HPV Afflicted Cervical Lesions by Employing CRISPR/Cas9 and Poly (Beta-Amino Ester)
par: Xiong J, et autres
Publié: (2021)

A Review of the Implementation Status of and National Plans on HPV Vaccination in 17 Middle-Income Countries of the WHO Western Pacific Region
par: Rei Haruyama, et autres
Publié: (2021)

CERVICAL NEOPLASIA AND VIRUS LOAD OF HPV 16 GENOTYPE
par: V. S. Chirsky, et autres
Publié: (2014)

Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis
par: Ruwen Yang, et autres
Publié: (2019)

Parents’ attitudes, beliefs and uptake of the school-based human papillomavirus (HPV) vaccination program in Jakarta, Indonesia – A quantitative study
par: Kurnia Eka Wijayanti, et autres
Publié: (2021)

Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years?
par: Martyna Trzeszcz, et autres
Publié: (2021)

Predictors of the Therapeutic Response to Intralesional Bivalent HPV Vaccine in Wart Immunotherapy
par: Noha M. Hammad, et autres
Publié: (2021)

Enhancer RNA Profiling in Smoking and HPV Associated HNSCC Reveals Associations to Key Oncogenes
par: Neil Shende, et autres
Publié: (2021)

Predictive Role of the p16 Immunostaining Pattern in Atypical Cervical Biopsies with Less Common High Risk HPV Genotypes
par: Daniela Cabibi, et autres
Publié: (2021)

HPV-16 E2/E6 and POU5F1B as Biomarkers to Determine Cervical High-Grade Squamous Lesions and More
par: Chen L, et autres
Publié: (2020)

Predictors, barriers and motivating factors for human papillomavirus vaccination and testing as preventive measures for cervical cancer: A study of urban women in Lagos, Nigeria
par: Adeyemi A. Okunowo, et autres
Publié: (2021)

Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study
par: Federica Inturrisi, et autres
Publié: (2021)

Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor
par: Wang S, et autres
Publié: (2017)

Bioinformatics analysis of putative causes for сross-reactive antibodies interacting with antigens derived from various pathogenic human papillomaviruses
par: A. S. Stolbikov, et autres
Publié: (2020)

Genital warts trends in Australian and overseas-born people in Australia: A cross-sectional trend analysis to measure progress towards control and elimination
par: Laila Khawar, MPH, et autres
Publié: (2021)

HPV-ASSOCIATED DISEASES IN THE STRUCTURE OF FEMALE REPRODUCTIVE TRACT TUMORS AND SEXUALLY TRANSMITTED INFECTIONS IN MOSCOW AND RUSSIA
par: N. I. Briko, et autres
Publié: (2018)

Clinical Effects of Oral Bacteriotherapy on Anal HPV Infection and Related Dysplasia in HIV-Positive MSM: Results from the “HPVinHIV” Trial
par: Eugenio Nelson Cavallari, et autres
Publié: (2021)

A very rare case of HPV-53-related cervical cancer, in a 79-year-old woman with a previous history of negative Pap cytology
par: Zappacosta R, et autres
Publié: (2014)

Expression of Chimeric HPV-HIV Protein L1P18 in <i>Pichia pastoris</i>; Purification and Characterization of the Virus-like Particles
par: Yoshiki Eto, et autres
Publié: (2021)

Stability analysis of an age-structured model of cervical cancer cells and HPV dynamics
par: Vitalii V. Akimenko, et autres
Publié: (2021)

Self-Assembled Nanofibers Elicit Potent HPV16 E7-Specific Cellular Immunity And Abolish Established TC-1 Graft Tumor
par: Li S, et autres
Publié: (2019)

HPV vaccine: uptake and understanding among global Indigenous communities – a qualitative systematic review
par: Brianna Poirier, et autres
Publié: (2021)

The Help of HPV Integration Testing to Avoid the Misdiagnosis of a Patient with Stage Ia1 Cervical Cancer: A Case Report and Literature Review
par: Li J, et autres
Publié: (2021)

MPS1 is involved in the HPV16-E7-mediated centrosomes amplification
par: Yair Alfaro-Mora, et autres
Publié: (2021)

Acceptability of human papillomavirus (HPV) self-sampling among never- and under-screened Indigenous and other minority women: a randomised three-arm community trial in Aotearoa New Zealand
par: Naomi Brewer, et autres
Publié: (2021)

Low frequency of HPV positivity in breast tumors among patients from south-central Poland
par: Beata Biesaga, et autres
Publié: (2021)

Who Should Decide? Decision-Making Preferences for Primary HPV Testing for Cervical Cancer Screening Among U.S. Women
par: Erika L. Thompson, et autres
Publié: (2021)

CURRENT APPROACHES TO THE DIAGNOSIS OF CERVICAL DISEASE IN PREGNANT
par: E. S. Sverdlova, et autres
Publié: (2013)

Organization of cervical cancer screening with DNA–HPV testing impact on early–stage cancer detection: a population–based demonstration study in a Brazilian city
par: Julio Cesar Teixeira, et autres
Publié: (2022)

Inactivation of Polyomavirus SV40 as Surrogate for Human Papillomaviruses by Chemical Disinfectants
par: Martin Hufbauer, et autres
Publié: (2021)

Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model
par: Chu X, et autres
Publié: (2016)

Potential for cervical cancer incidence and death resulting from Japan’s current policy of prolonged suspension of its governmental recommendation of the HPV vaccine
par: Asami Yagi, et autres
Publié: (2020)